Mesoblast Limited Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Mesoblast Limited, an Australian company, on December 12, 2019. The report covers the month of December 2019 and pertains to regulatory disclosures required under the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of corporate governance events rather than a financial performance statement.
Material Changes
The primary material event disclosed is the submission of Change in Director's Interest Notice forms to the Australian Securities Exchange on December 5, 2019. These notices are attached as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investors to Verify
- Review Exhibit 99.1 (Appendix 3Y) for specific details regarding the changes in directors' interests.
- Confirm the identity of the directors involved in the interest changes.
- Verify the nature and magnitude of the interest changes disclosed in the attached notices.